- Home
- INBK vs MCRB Comparison
INBK vs MCRB Comparison
Compare INBK & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBK
- MCRB
- Stock Information
- Founded
- INBK 1999
- MCRB 2010
- Country
- INBK United States
- MCRB United States
- Employees
- INBK N/A
- MCRB N/A
- Industry
- INBK Major Banks
- MCRB Biotechnology: Pharmaceutical Preparations
- Sector
- INBK Finance
- MCRB Health Care
- Exchange
- INBK Nasdaq
- MCRB Nasdaq
- Market Cap
- INBK 191.0M
- MCRB 165.3M
- IPO Year
- INBK N/A
- MCRB 2015
- Fundamental
- Price
- INBK $24.10
- MCRB $17.61
- Analyst Decision
- INBK Hold
- MCRB Hold
- Analyst Count
- INBK 3
- MCRB 4
- Target Price
- INBK $30.67
- MCRB $73.67
- AVG Volume (30 Days)
- INBK 32.6K
- MCRB 247.1K
- Earning Date
- INBK 10-22-2025
- MCRB 11-12-2025
- Dividend Yield
- INBK 1.01%
- MCRB N/A
- EPS Growth
- INBK N/A
- MCRB N/A
- EPS
- INBK 1.76
- MCRB 10.22
- Revenue
- INBK $106,219,000.00
- MCRB N/A
- Revenue This Year
- INBK $5.27
- MCRB N/A
- Revenue Next Year
- INBK $27.40
- MCRB N/A
- P/E Ratio
- INBK $13.56
- MCRB $1.71
- Revenue Growth
- INBK 4.74
- MCRB N/A
- 52 Week Low
- INBK $19.54
- MCRB $6.53
- 52 Week High
- INBK $43.27
- MCRB $24.67
- Technical
- Relative Strength Index (RSI)
- INBK 48.34
- MCRB 50.98
- Support Level
- INBK $23.52
- MCRB $14.22
- Resistance Level
- INBK $24.67
- MCRB $24.67
- Average True Range (ATR)
- INBK 0.77
- MCRB 2.02
- MACD
- INBK -0.07
- MCRB -0.47
- Stochastic Oscillator
- INBK 30.47
- MCRB 32.46
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.